Barings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-739
Closed -$260K 175
2023
Q2
$260K Hold
739
0.01% 153
2023
Q1
$233K Buy
+739
New +$233K 0.01% 151
2022
Q3
Sell
-1,723
Closed -$486K 322
2022
Q2
$486K Buy
+1,723
New +$486K 0.02% 204
2022
Q1
Sell
-1,135
Closed -$249K 390
2021
Q4
$249K Buy
+1,135
New +$249K 0.01% 351
2021
Q3
Sell
-5,671
Closed -$1.14M 440
2021
Q2
$1.14M Sell
5,671
-126
-2% -$25.4K 0.03% 202
2021
Q1
$1.25M Sell
5,797
-482
-8% -$104K 0.03% 208
2020
Q4
$1.48M Sell
6,279
-15,561
-71% -$3.68M 0.04% 191
2020
Q3
$5.94M Buy
21,840
+7,804
+56% +$2.12M 0.14% 125
2020
Q2
$3.34M Hold
14,036
0.11% 152
2020
Q1
$3.34M Sell
14,036
-412
-3% -$98K 0.11% 152
2019
Q4
$3.16M Sell
14,448
-7,171
-33% -$1.57M 0.08% 186
2019
Q3
$3.66M Sell
21,619
-752
-3% -$127K 0.08% 185
2019
Q2
$4.1M Buy
22,371
+6,842
+44% +$1.25M 0.09% 185
2019
Q1
$2.86M Buy
15,529
+7,952
+105% +$1.46M 0.07% 216
2018
Q4
$1.26M Buy
7,577
+1,715
+29% +$284K 0.02% 337
2018
Q3
$1.13M Hold
5,862
0.02% 462
2018
Q2
$996K Buy
5,862
+3,202
+120% +$544K 0.01% 507
2018
Q1
$434K Hold
2,660
0.01% 731
2017
Q4
$399K Buy
+2,660
New +$399K 0.01% 771
2016
Q1
Sell
-2,300
Closed -$289K 980
2015
Q4
$289K Hold
2,300
0.01% 776
2015
Q3
$240K Hold
2,300
0.01% 800
2015
Q2
$284K Hold
2,300
0.01% 827
2015
Q1
$271K Hold
2,300
0.01% 836
2014
Q4
$273K Hold
2,300
0.01% 805
2014
Q3
$258K Hold
2,300
0.01% 836
2014
Q2
$218K Buy
+2,300
New +$218K 0.01% 909